Dr. Tamara Yvette Brown, MD

Dr. Brown practices at Tamara Brown, MD in Atlanta, Georgia.

Dr. Brown's NPI, 1174571715, was assigned on May 5, 2006. Dr. Brown graduated from Howard University College of Medicine in 1994. Dr. Brown holds Georgia license 040620.

Dr. Brown's primary practice is Tamara Brown, MD, at 5835 Campbellton SW Rd, Atlanta, GA 30331 in Fulton County. The practice phone is (404) 696-4141.

Dr. Brown's primary practice is Tamara Brown, MD in Atlanta, Georgia. Dr. Brown is also affiliated with Emory University Hospital Midtown. Dmand AI also links Dr. Brown to 4 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brown practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Brown's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Brown is board certified in internal medicine by the American Board of Internal Medicine. Dr. Brown is licensed in Georgia.

CMS data shows 778 Medicare services from Dr. Brown across 13 procedure codes in 2024, for 97 Medicare patients. Medicare paid $50,660 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Brown in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 0.79, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brown's median patient age at 63, with 78% women.

In 2024, Dr. Brown wrote 4,982 Medicare Part D claims for 338 patients. 80% of them were for generic drugs. CMS names the drug for 4,439 of them, across 88 drugs with 11 or more claims each, at $714,761 in total drug cost. In 2023, CMS named 3,613 claims across 83 drugs.

Dr. Brown accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Brown to 1 clinical trial. Conditions studied include Diabetes Mellitus, Type 2 and Diabetes Mellitus. Open Payments lists research payments to Dr. Brown that name 1 trial.

CMS Open Payments shows 593 general payments to Dr. Brown from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Novo Nordisk Inc paid the most, $1,423. It also lists 2 research payments totaling $14,197 in 2019, naming 1 clinical trial.

Dr. Brown graduated from Howard University College of Medicine in 1994.